Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid LeukemiaNicolas Chapuis, Didier Bouscary, Jérôme Tamburini et al.|Clinical Cancer Research|2010Cited by 159